Management of Crohn's Disease and Complications in Patients With Ostomies.
Fecal diversion with ostomy construction can be a temporary or definitive surgical measure for the treatment of refractory inflammatory bowel disease (IBD). However, the fecal diversion surgery is associated with various stoma, peristomal complications, and recurrence or occurrence of de novo small...
| Publicado en: | Inflammatory Bowel Diseases Vol. 24; no. 6; pp. 1167 - 1185 |
|---|---|
| Autores principales: | , |
| Formato: | diagnostic images pictorial review tables/charts Journal Article |
| Publicado: |
Oxford University Press / USA
Jun2018
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=130119640&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 130119640 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 10780998 N0V jtl: Inflammatory Bowel Diseases issn: 10780998 maglogo: N pubinfo: dt: Jun2018 vid: 24 iid: 6 pid: 622 pub: Oxford University Press / USA artinfo: ui: 130119640 130119640 130119640 10.1093/ibd/izy025 130119640 ppf: 1167 ppct: 18 formats: tig: atl: Management of Crohn's Disease and Complications in Patients With Ostomies. aug: au: Wang, Xinying Shen, Bo affil: Department of Gastroenterology, Zhujiang Hospital, Southern Medical University, Guangzhou, China sug: subj: Crohn Disease Surgery Ostomy Adverse Effects Postoperative Complications Inflammatory Bowel Diseases Surgery Pyoderma Gangrenosum Therapy Immunologic Factors Therapeutic Use Biological Therapy Reoperation Crohn Disease Diagnosis Endoscopy Methods Mesalamine Therapeutic Use Antibiotics Therapeutic Use Tumor Necrosis Factor Adrenal Cortex Hormones Phenotype Treatment Outcomes ab: Fecal diversion with ostomy construction can be a temporary or definitive surgical measure for the treatment of refractory inflammatory bowel disease (IBD). However, the fecal diversion surgery is associated with various stoma, peristomal complications, and recurrence or occurrence of de novo small bowel Crohn's disease (CD). Stoma complications often need enterostomal therapy or surgical revision. Peristomal cutaneous lesions, such as pyoderma gangrenosum, usually require immunomodulator or biological therapy. Routine monitoring for occurrence or recurrence of CD with endoscopy or imaging should be performed, and prophylaxis with mesalamines, antibiotics, immunomodulators, or anti-TNFα or anti-integrin agents is needed for patients at risk. Those agents, along with corticosteroids, may also be used for the treatment of CD of the neo-small intestine, particularly inflammatory and fistulizing phenotypes. Endoscopic balloon dilation or endoscopic stricturotomy via stoma is safe and feasible to treat short (<4–5 cm), straight strictures in the neo-small intestine. Medically or endoscopically refractory fibrostenotic disease usually requires surgical intervention, with bowel-sparing stricturoplasty being the surgical treatment of choice. pubtype: Academic Journal doctype: diagnostic images pictorial review tables/charts Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|